Evidence map›Paper›PMID 37305780›Full record

ReviewJournal of biomedical optics2023

Feasibility of postprandial optical scattering of lipoproteins in blood as an optical marker of cardiovascular disease risk: modeling and experimental validation.

Anahita Pilvar, Declan W Smith, Jorge Plutzky, Darren Roblyer

Open access · goldAbstract readReview
In one paragraph

Review in Journal of biomedical optics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Anahita PilvarBoston University, Department of Electrical and Computer Engineering, Boston, Massachusetts, United States.ORCID 0000-0002-3341-0079
Declan W SmithBoston University, Department of Physics, Boston, Massachusetts, United States.ORCID 0009-0009-5079-7808
Jorge PlutzkyBrigham and Women's Hospital and Harvard Medical School, Department of Medicine, Boston, Massachusetts, United States.
Darren RoblyerBoston University, Department of Electrical and Computer Engineering, Boston, Massachusetts, United States.ORCID 0000-0002-5301-4364
Boston University · USHarvard University · USInstitute of Biomedical Science · GB

Funding

Label-free measurement of blood lipids with hyperspectral short-wave infrared spatial frequency domain imaging to improve cardiovascular disease risk prediction and treatment monitoringR21EB030197 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI ROBLYER, DARREN MICHAEL · 2020 to 2022
$685k
NIBIB NIH HHS R21 EB030197
6 · The paper itself

Abstract

Significance: Blood lipid levels (i.e., triglycerides (TGs) and cholesterol) are a strong predictor of cardiovascular disease (CVD) risk. Current methods for measuring blood lipids require invasive blood draws and traditional lab testing, limiting their practicality for frequent monitoring. Optical measurements of lipoproteins, which carry TG and cholesterol in blood, may lead to simpler invasive or non-invasive methods for more frequent and rapid blood lipid measurements. Aim: To investigate the effect of lipoproteins on optical properties of blood before and after a high-fat meal (i.e., the pre- and post-prandial state). Approach: Simulations were performed using Mie theory to estimate lipoprotein scattering properties. A literature review was conducted to identify key simulation parameters including lipoprotein size distributions and number density. Experimental validation of Results: Our results indicated that lipoproteins in blood, particularly very low-density lipoproteins and chylomicrons, are highly scattering in the visible and near-infrared wavelength region. Estimates of the increase in the reduced scattering coefficient ( Conclusion: These findings lay the foundation for future research in the development of optical methods for invasive and non-invasive optical measure of blood lipoproteins, which could improve early detection and management of CVD risk.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2AnisotropyFeasibility StudiesHumansLipoproteinsLipoproteinsblood lipidsblood optical propertiescardiovascular diseasediffuse opticslipoproteinsoptical scatteringspatial frequency domain imaging

Identifiers

PMID37305780
PMCPMC10249051
OpenAlexW4380046213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.